PURPOSE: A reciprocal relationship exists between the skin and the GH/IGF-I axis. Skin produces both IGF- I and vitamin D, and GH and IGF-I exert several actions in the skin. Reduced sweating and altered phosphor-calcium homeostasis are occasionally reported in subjects with GH deficiency (GHD), mostly in the setting of hypopituitarism, therefore associated to other hormonal deficiencies. It is unclear whether these findings are due to GHD. The aim of this study was to assess skin function in subjects with isolated GHD (IGHD) due to a mutation in the GHRH receptor gene. METHODS: In a cross-sectional study we enrolled 20 IGHD and 20 local controls. Sweating (volume, conductivity and chloride content) was assessed by a 30 min pilocarpine iontophoresis test, using the Macroduct® Sweat Collection System. IGF-I, Insulin, PTH, 25-hydroxyvitamin D, C-reactive protein (CRP), CPK, glucose, calcium, phosphate, alkaline phosphatase, total proteins and fractions, urinary calcium, and insulin were measured. HOMA-IR was calculated. RESULTS: IGHD presented lower sweating, but normal vitamin D and phosphor-calcium homeostasis. Additionally, IGHD subjects presented lower HOMA-IR, higher CRP and reduced CPK. CONCLUSION: Untreated IGHD cause reduction in sweating, but does not affect phosphor-calcium homeostasis.
PURPOSE: A reciprocal relationship exists between the skin and the GH/IGF-I axis. Skin produces both IGF- I and vitamin D, and GH and IGF-I exert several actions in the skin. Reduced sweating and altered phosphor-calcium homeostasis are occasionally reported in subjects with GH deficiency (GHD), mostly in the setting of hypopituitarism, therefore associated to other hormonal deficiencies. It is unclear whether these findings are due to GHD. The aim of this study was to assess skin function in subjects with isolated GHD (IGHD) due to a mutation in the GHRH receptor gene. METHODS: In a cross-sectional study we enrolled 20 IGHD and 20 local controls. Sweating (volume, conductivity and chloride content) was assessed by a 30 min pilocarpine iontophoresis test, using the Macroduct® Sweat Collection System. IGF-I, Insulin, PTH, 25-hydroxyvitamin D, C-reactive protein (CRP), CPK, glucose, calcium, phosphate, alkaline phosphatase, total proteins and fractions, urinary calcium, and insulin were measured. HOMA-IR was calculated. RESULTS:IGHD presented lower sweating, but normal vitamin D and phosphor-calcium homeostasis. Additionally, IGHD subjects presented lower HOMA-IR, higher CRP and reduced CPK. CONCLUSION: Untreated IGHD cause reduction in sweating, but does not affect phosphor-calcium homeostasis.
Authors: S A Pedersen; K Welling; K F Michaelsen; J O Jørgensen; J S Christiansen; N E Skakkebaek Journal: Lancet Date: 1989-09-16 Impact factor: 79.321
Authors: Cindi G Marinho; Lívia M Mermejo; Roberto Salvatori; João A Assirati; Carla R P Oliveira; Elenilde G Santos; Ângela C G B Leal; Cynthia S Barros-Oliveira; Nayra P Damascena; Carlos A Lima; Catarine T Farias; Ayrton C Moreira; Manuel H Aguiar-Oliveira Journal: Growth Horm IGF Res Date: 2018-03-12 Impact factor: 2.372
Authors: R Salvatori; C Y Hayashida; M H Aguiar-Oliveira; J A Phillips; A H Souza; R G Gondo; S P Toledo; M M Conceicão; M Prince; H G Maheshwari; G Baumann; M A Levine Journal: J Clin Endocrinol Metab Date: 1999-03 Impact factor: 5.958
Authors: M Lange; J Thulesen; U Feldt-Rasmussen; N E Skakkebaek; N Vahl; J O Jørgensen; J S Christiansen; S S Poulsen; S B Sneppen; A Juul Journal: Eur J Endocrinol Date: 2001-08 Impact factor: 6.664
Authors: Pietro Ameri; Andrea Giusti; Mara Boschetti; Giovanni Murialdo; Francesco Minuto; Diego Ferone Journal: Clin Endocrinol (Oxf) Date: 2013-08-09 Impact factor: 3.478
Authors: Cindi G Marinho; Hyder A Melo; Roberto Salvatori; Marco A P Nunes; Carla R P Oliveira; Viviane C Campos; Cynthia S Barros-Oliveira; Alécia A Oliveira-Santos; Nelmo V Menezes; Hertz T Santos-Júnior; Elenilde G Santos; Manuela A Melo; Joselina L M Oliveira; Enaldo V Melo; Manuel H Aguiar-Oliveira Journal: Endocrine Date: 2020-07-12 Impact factor: 3.633
Authors: Manuela A Melo; Lysandro P Borges; Roberto Salvatori; Daniela R V Souza; Hertz T Santos-Júnior; José M de R Neto; Viviane C Campos; Aryanne A Santos; Carla R P Oliveira; Grazielly B da Invenção; Vanderlan O Batista; Igor L S Matos; Cynthia S Barros-Oliveira; Kezia A Dos Santos; Elenilde G Santos; Nicolas A A Souza; Enaldo V Melo; Pamela C Borges; Saulo E F S Santos; Brenda M de Oliveira; Alécia A Oliveira-Santos; Amélia R de Jesus; Manuel H Aguiar-Oliveira Journal: Endocrine Date: 2021-04-16 Impact factor: 3.633